Norepinephrine reuptake inhibitor - PDFSEARCH.IO - Document Search Engine

Norepinephrine reuptake inhibitor
Results: 264

#	Item
101	What You Need to Know… Depression and African Americans Not Just the Blues Clinical depression is more than life’s “ups” and “downs.” Life is full of joy and pain, happiness and sorrow. It is normal to feel s Add to Reading List Source URL: www.mhawisconsin.org Language: English - Date: 2011-10-03 15:01:40 Abnormal psychology Major depressive disorder Antidepressant Depression Mental disorder Mental health Serotonin–norepinephrine–dopamine reuptake inhibitor Late life depression Psychiatry Mood disorders Mind
102	Kentucky Department for Medicaid Services Add to Reading List Source URL: chfs.ky.gov Language: English - Date: 2014-11-26 18:46:33 Abnormal psychology Serotonin–norepinephrine reuptake inhibitor Fibromyalgia Monoamine oxidase inhibitors Duloxetine Antidepressant Generalized anxiety disorder Venlafaxine Panic disorder Psychiatry Medicine Anxiety disorders
103	Print Form Reset Form CHILDREN’S MEDICAL SERVICES NETWORK Prior Authorization Add to Reading List Source URL: ahca.myflorida.com Language: English - Date: 2014-07-29 11:25:15 Mental health Mood disorders Bipolar spectrum Anxiety disorders Antidepressant Pharmacology Major depressive disorder Panic disorder Serotonin–norepinephrine–dopamine reuptake inhibitor Psychiatry Emotion Abnormal psychology
104	Celexa (escitalopram oxalate) tablets/oral solution label Add to Reading List Source URL: www.fda.gov Language: English Selective serotonin reuptake inhibitors Nitriles Enantiopure drugs Escitalopram Pimozide Antidepressant Serotonin–norepinephrine reuptake inhibitor Lundbeck Forest Laboratories Chemistry Organic chemistry Organofluorides
105	Print Form Reset Form CHILDREN’S MEDICAL SERVICES NETWORK Prior Authorization Add to Reading List Source URL: www.fdhc.state.fl.us Language: English - Date: 2014-07-29 11:25:15 Mental health Mood disorders Bipolar spectrum Anxiety disorders Antidepressant Pharmacology Major depressive disorder Panic disorder Serotonin–norepinephrine–dopamine reuptake inhibitor Psychiatry Emotion Abnormal psychology
106	Print Form Reset Form CHILDREN’S MEDICAL SERVICES NETWORK Prior Authorization Add to Reading List Source URL: www.fdhc.state.fl.us Language: English - Date: 2014-07-29 11:25:15 Mental health Mood disorders Bipolar spectrum Anxiety disorders Antidepressant Pharmacology Major depressive disorder Panic disorder Serotonin–norepinephrine–dopamine reuptake inhibitor Psychiatry Emotion Abnormal psychology
107	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Language: English Duloxetine Eli Lilly and Company Thiophenes Organic chemistry Serotonin–norepinephrine reuptake inhibitor Serotonin-norepinephrine reuptake inhibitors Chemistry Amines
108	June 3, 2004 Dear Health Care Professional, Wyeth wishes to inform you about important safety information that the U.S. Food and Drug Administration (FDA) has asked the manufacturers of ten antidepressants, including Ef Add to Reading List Source URL: www.fda.gov Language: English Alcohols Mood disorders Organochlorides Venlafaxine Serotonin–norepinephrine reuptake inhibitor Antidepressant Pfizer Generalized anxiety disorder Selective serotonin reuptake inhibitor Chemistry Psychiatry Medicine
109	Effexor XR® (venlafaxine hydrochloride) Extended-Release Capsules Rx only Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-07-08 15:36:52 Alcohols Anxiety disorders Venlafaxine Abnormal psychology Serotonin-norepinephrine reuptake inhibitors Desvenlafaxine Antidepressant Panic disorder Selective serotonin reuptake inhibitor Psychiatry Chemistry Medicine
110	NEWSFOCUS Is Pharma Running Out of Brainy Ideas? These cutbacks by two of the top players in drug development for disorders of the Add to Reading List Source URL: www.brainm.com Language: English - Date: 2010-08-05 09:23:52 Pharmaceutical industry AstraZeneca Antidepressant National Institute of Mental Health Drug development Pharmaceutical drug GlaxoSmithKline Serotonin–norepinephrine–dopamine reuptake inhibitor Pharmacology Pharmaceutical sciences Clinical research

UPDATE